EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance Evaluation of the VISITECT CD4 Lateral Flow Point‐Of‐Care Assay for Identifying Advanced HIV Disease

Mariana Andreani iD, Claudia E Frola, Liliana Guelfand, Fabiana C Chaile, José Barletta, María J Rolón, Mariana Erbin, Juan L Rodriguez-Tudela

Journal of Clinical Laboratory Analysis · 2026

DOI: 10.1002/jcla.70340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Mariana Andreani und 7 weiteren Autor:innen. Beteiligte Einrichtung: División Laboratorio de Análisis Clínicos, Sección Microbiología, Hospital General de Agudos "Dr. Juan A. Fernández", Buenos Aires, Argentina. Hauptthemen laut MEDLINE: HIV Infections, Point-of-Care Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCEZID CDC HHS, Global Action For Fungal Infections (GAFFI), Centers for Disease Control and Prevention (CDC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the performance and reader‐dependent variability of the VISITECT CD4 lateral flow assay (LFA) as a screening tool for identifying advanced HIV disease (AHD; CD4 ≤ 200 cells/μL) during routine programmatic implementation.

Methods

We conducted a two‐phase diagnostic evaluation in Argentina, including a training phase ( n = 100) and a validation phase ( n = 249), for a total of 349 participants, comparing VISITECT CD4‐LFA with flow cytometry. Diagnostic performance was assessed using the manufacturer‐recommended cut‐off. Sensitivity, specificity, and accuracy were calculated with 95% confidence intervals (CI). Receiver operating characteristic (ROC) analysis was used to estimate the implicit CD4 thresholds applied by readers.

Results

The VISITECT CD4‐LFA showed 100% sensitivity (95% CI 94–100) in both phases. Specificity improved from 19% (95% CI 8–35) to 40% (95% CI 31–49) after training, with accuracy increasing from 42% (95% CI 33–53) to 57% (95% CI 51–63). ROC analysis demonstrated a shift in the implicit reader threshold from 363 to 270 cells/μL, indicating improved interpretation with experience.

Conclusions

The VISITECT CD4‐LFA is a highly sensitive point‐of‐care (POC) tool for AHD screening, though its visual design limits specificity, highlighting the need for reader‐independent technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPoint-of-Care SystemsHumansSensitivity and SpecificityFemaleROC CurveMaleAdultCD4 Lymphocyte CountFlow CytometryRapid Diagnostic TestsMiddle AgedCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

CD4 countadvanced HIV diseasediagnostic performancelateral flow assaypoint‐of‐care testing

Autor:innen und Institutionen

  • División Laboratorio de Análisis Clínicos, Sección Microbiología, Hospital General de Agudos "Dr. Juan A. Fernández", Buenos Aires, Argentina.
  • División Infectología, Hospital General de Agudos "Dr. Juan A. Fernández", Buenos Aires, Argentina.
  • Global Action for Fungal Infections (GAFFI), Geneva, Switzerland.

ORCID-Profile: Mariana Andreani

Förderung

  • NCEZID CDC HHS
  • Global Action For Fungal Infections (GAFFI)
  • Centers for Disease Control and Prevention (CDC)

Zitieren

APA

Andreani, M., Frola, C. E., Guelfand, L., Chaile, F. C., Barletta, J., Rolón, M. J., Erbin, M., & Rodriguez-Tudela, J. L. (2026). Performance Evaluation of the VISITECT CD4 Lateral Flow Point‐Of‐Care Assay for Identifying Advanced HIV Disease. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70340

Vancouver

Andreani M, Frola CE, Guelfand L, Chaile FC, Barletta J, Rolón MJ, et al. Performance Evaluation of the VISITECT CD4 Lateral Flow Point‐Of‐Care Assay for Identifying Advanced HIV Disease. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70340

BibTeX
@article{Andreani2026,
  author = {Andreani, Mariana and Frola, Claudia E and Guelfand, Liliana and Chaile, Fabiana C and Barletta, José and Rolón, María J and Erbin, Mariana and Rodriguez-Tudela, Juan L},
  title = {Performance Evaluation of the VISITECT CD4 Lateral Flow Point‐Of‐Care Assay for Identifying Advanced HIV Disease},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  doi = {10.1002/jcla.70340}
}
Kostenlos starten →